Consolidated Statements of Cash Flows - USD ($) $ in Millions		9 Months Ended
		Nov. 01, 2015	Nov. 02, 2014
OPERATING ACTIVITIES
Net Income		$ 438.2	$ 387.4
Adjustments to reconcile to net cash provided by operating activities:
Depreciation and amortization		187.0	181.4
Equity in net income of unconsolidated affiliates		(15.0)	(9.2)
Deferred taxes		(15.6)	(33.7)
Stock-based compensation expense		31.4	37.3
Impairment of long-lived assets		2.8	4.8
Debt modification and extinguishment costs		0.0	93.1
Net gain on deconsolidation of subsidiaries and joint venture		0.0	(8.0)
Changes in operating assets and liabilities:
Trade receivables, net		(132.3)	(168.8)
Inventories, net		(94.1)	4.4
Accounts payable, accrued expenses and deferred revenue		(90.9)	(177.5)
Prepaid expenses		(0.3)	(45.1)
Employer pension contributions		(1.5)	(2.7)
Other, net		78.4	60.5
Net cash provided by operating activities		388.1	323.9
INVESTING ACTIVITIES(1)
Business acquisitions		0.0	(14.7)
Purchase of property, plant and equipment		(169.0)	(173.5)
Contingent purchase price payments		(35.0)	(35.5)
Decrease in restricted cash		20.2	9.7
Investments in unconsolidated affiliates		(26.6)	(26.2)
Net cash used by investing activities	[1]	(210.4)	(240.2)
FINANCING ACTIVITIES(1)
Net proceeds from short-term borrowings		19.1	31.6
Redemption of 7 3/8% senior notes, including make whole premium		0.0	(667.6)
Proceeds from 2014 facilities, net of related fees		0.0	586.7
Repayment of 2014 facilities		(200.5)	(244.7)
Net proceeds from settlement of awards under stock plans		5.7	9.5
Excess tax benefits from awards under stock plans		5.0	9.3
Cash dividends		(12.5)	(12.5)
Acquisition of treasury shares		(87.3)	(10.5)
Payments of capital lease obligations		(5.6)	(6.6)
Net cash used by financing activities	[1]	(276.1)	(304.8)
Effect of exchange rate changes on cash and cash equivalents		(11.0)	(7.0)
Decrease in cash and cash equivalents		(109.4)	(228.1)
Cash and cash equivalents at beginning of period		479.3	593.2
Cash and cash equivalents at end of period		$ 369.9	$ 365.1

[1] See Note 17 for information on noncash investing and financing transactions.